Brief: Demant Sees 2026 EBIT Before Special Items Of DKK 4.1-4.5 Bln

Demant A/S

03/02/2026 07:09

Feb 3 (Reuters) - Demant A/S DEMANT.CO:

OUTLOOK FOR 2026: ORGANIC GROWTH OF 3-6% AND EBIT BEFORE SPECIAL ITEMS OF DKK 4,100-4,500 MILLION

Q4 REVENUE DKK 6,264 MILLION VERSUS DKK 6,123 MILLION SEEN IN COMPANY CONSENSUS

Q4 ORGANIC GROWTH 5% VERSUS 2.8% SEEN IN COMPANY COMPILED CONSENSUS

HEARING AIDS SAW ORGANIC GROWTH FROM EXTERNAL CUSTOMERS OF 3% (Q4: 4%), AND WE ESTIMATE THAT WE GAINED MARKET SHARE IN TERMS OF BOTH UNITS AND VALUE IN Q4

WILL INCUR COSTS RECOGNISED UNDER SPECIAL ITEMS OF AROUND DKK 200 MILLION IN 2026 AND DKK 100 MILLION IN 2027 PRIMARILY RELATED TO SEVERANCE PAYMENTS

DESPITE TOUGH COMPARATIVE FIGURES, HEARING CARE CONTINUED TO DELIVER A SOLID PERFORMANCE IN A WEAKER-THAN-NORMAL HEARING AID MARKET WITH ORGANIC GROWTH OF 4% (Q4: 5%)

Source text: ID:nRBB9vZ75F

Further company coverage: DEMANT.CO

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))